Matches in Wikidata for { <http://www.wikidata.org/entity/Q39205581> ?p ?o ?g. }
- Q39205581 description "2016 nî lūn-bûn" @default.
- Q39205581 description "2016 թվականի նոյեմբերի 4-ին հրատարակված գիտական հոդված" @default.
- Q39205581 description "2016年の論文" @default.
- Q39205581 description "2016年論文" @default.
- Q39205581 description "2016年論文" @default.
- Q39205581 description "2016年論文" @default.
- Q39205581 description "2016年論文" @default.
- Q39205581 description "2016年論文" @default.
- Q39205581 description "2016年论文" @default.
- Q39205581 description "2016年论文" @default.
- Q39205581 description "2016年论文" @default.
- Q39205581 description "2016年论文" @default.
- Q39205581 description "2016年论文" @default.
- Q39205581 description "2016年论文" @default.
- Q39205581 description "2016년 논문" @default.
- Q39205581 description "article científic" @default.
- Q39205581 description "article scientific" @default.
- Q39205581 description "article scientifique" @default.
- Q39205581 description "articol științific" @default.
- Q39205581 description "articolo scientifico" @default.
- Q39205581 description "artigo científico" @default.
- Q39205581 description "artigo científico" @default.
- Q39205581 description "artigo científico" @default.
- Q39205581 description "artikel ilmiah" @default.
- Q39205581 description "artikull shkencor" @default.
- Q39205581 description "artikulong pang-agham" @default.
- Q39205581 description "artykuł naukowy" @default.
- Q39205581 description "artículo científico publicado en 2016" @default.
- Q39205581 description "artículu científicu espublizáu en 2016" @default.
- Q39205581 description "bilimsel makale" @default.
- Q39205581 description "bài báo khoa học" @default.
- Q39205581 description "naučni članak" @default.
- Q39205581 description "scienca artikolo" @default.
- Q39205581 description "scientific article published on 4 November 2016" @default.
- Q39205581 description "scientific article published on 4 November 2016" @default.
- Q39205581 description "scientific article published on 4 November 2016" @default.
- Q39205581 description "teaduslik artikkel" @default.
- Q39205581 description "tieteellinen artikkeli" @default.
- Q39205581 description "tudományos cikk" @default.
- Q39205581 description "vedecký článok" @default.
- Q39205581 description "vetenskaplig artikel" @default.
- Q39205581 description "videnskabelig artikel" @default.
- Q39205581 description "vitenskapelig artikkel" @default.
- Q39205581 description "vitskapeleg artikkel" @default.
- Q39205581 description "vědecký článek" @default.
- Q39205581 description "wetenschappelijk artikel" @default.
- Q39205581 description "wissenschaftlicher Artikel" @default.
- Q39205581 description "επιστημονικό άρθρο" @default.
- Q39205581 description "мақолаи илмӣ" @default.
- Q39205581 description "наукова стаття, опублікована в листопаді 2016" @default.
- Q39205581 description "научна статия" @default.
- Q39205581 description "научная статья" @default.
- Q39205581 description "научни чланак" @default.
- Q39205581 description "научни чланак" @default.
- Q39205581 description "מאמר מדעי" @default.
- Q39205581 description "مقالة علمية نشرت في 4 نوفمبر 2016" @default.
- Q39205581 description "৪ নভেম্বর ২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q39205581 description "บทความทางวิทยาศาสตร์" @default.
- Q39205581 description "სამეცნიერო სტატია" @default.
- Q39205581 name "Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant (AFQ056)." @default.
- Q39205581 name "Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant (AFQ056)." @default.
- Q39205581 name "Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant" @default.
- Q39205581 type Item @default.
- Q39205581 label "Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant (AFQ056)." @default.
- Q39205581 label "Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant (AFQ056)." @default.
- Q39205581 label "Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant" @default.
- Q39205581 prefLabel "Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant (AFQ056)." @default.
- Q39205581 prefLabel "Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant (AFQ056)." @default.
- Q39205581 prefLabel "Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant" @default.
- Q39205581 P1433 Q39205581-06DE1646-09BA-482F-A0D6-FDCF56E8D4C3 @default.
- Q39205581 P1476 Q39205581-CB1C003F-8CBB-460C-89D5-9074DCF62B7F @default.
- Q39205581 P2093 Q39205581-05CCD97F-59D1-4933-A30B-BD8484AA2246 @default.
- Q39205581 P2093 Q39205581-21AEF31E-A65F-4CB8-8EBF-1206168E8EE2 @default.
- Q39205581 P2093 Q39205581-2C7E1356-CA23-4306-9826-3CEB83997765 @default.
- Q39205581 P2093 Q39205581-3E52ADCF-091F-4BF3-8AE1-9CCCFAD7663E @default.
- Q39205581 P2093 Q39205581-548C69D6-06B0-4333-B67E-FF8519E086B0 @default.
- Q39205581 P2093 Q39205581-A101D075-D45D-4446-8C36-A8CD1B4A8111 @default.
- Q39205581 P2093 Q39205581-C2AC28D1-BAD0-42EE-8CBB-5A14B6EF4487 @default.
- Q39205581 P2093 Q39205581-C7C5DBC7-055C-40F9-92E4-A1069321A738 @default.
- Q39205581 P2093 Q39205581-D60A283F-EEBD-46CC-A67D-B0612D5BACCC @default.
- Q39205581 P2093 Q39205581-F68E1923-FD44-4B31-B296-E5694D7A9B09 @default.
- Q39205581 P304 Q39205581-16A21BAE-FFAE-41BD-9558-D5C9C5712274 @default.
- Q39205581 P31 Q39205581-089624F8-1770-475A-980E-EB8C824B9551 @default.
- Q39205581 P356 Q39205581-6B530519-7C8A-4F13-B2C8-DD6C37611471 @default.
- Q39205581 P433 Q39205581-50392741-6348-4FE7-A95A-C02EA721B587 @default.
- Q39205581 P478 Q39205581-F6C89E2D-4612-43D2-8559-EF826DFF7547 @default.
- Q39205581 P577 Q39205581-94D10D71-61FF-4AB6-A1E4-B96A06027672 @default.
- Q39205581 P698 Q39205581-1C03BCB5-402C-42A3-BB7E-26438BD38228 @default.
- Q39205581 P8608 Q39205581-4C98F2F0-7AAD-41D7-BEF0-B7010B448F79 @default.
- Q39205581 P921 Q39205581-C763DCA3-BDBE-4624-9436-E387E533CCC1 @default.
- Q39205581 P356 J.CLINTHERA.2016.10.007 @default.
- Q39205581 P698 27823869 @default.
- Q39205581 P1433 Q15716601 @default.
- Q39205581 P1476 "Intravenous Dosing as an Alternate Approach to Safely Achieve Supratherapeutic Exposure for Assessments of Cardiac Repolarization: A Randomized Clinical Trial with Mavoglurant (AFQ056)." @default.
- Q39205581 P2093 "Alexandros Sagkriotis" @default.
- Q39205581 P2093 "Angela Dodman" @default.
- Q39205581 P2093 "Anne Tisserant" @default.
- Q39205581 P2093 "Atish Salunke" @default.
- Q39205581 P2093 "Emilie Voltz" @default.
- Q39205581 P2093 "Eric Legangneux" @default.